AI Article Synopsis
- The study aimed to compare the severity of symptoms and health-related quality of life in women who underwent laparoscopic versus robotic myomectomy for uterine fibroids.
- Using a cohort of 33 laparoscopic and 31 robotic patients, researchers found significant improvements in symptom severity and quality of life for both groups one year post-surgery.
- While both procedures showed comparable rates of improvement, the laparoscopy group had slightly better outcomes, but the difference was not statistically significant.
Article Abstract
Background And Objectives: To compare the symptom severity and health quality outcomes of women who underwent laparoscopic and robotic myomectomy.
Methods: This was a prospective nonrandomized cohort study. The Uterine Fibroid Symptom and Health Related Quality of Life Questionnaire was administered to 33 laparoscopic myomectomy and 31 robotic myomectomy patients before and year after surgery. Symptom severity and health quality scores were compared between the preoperative and postoperative periods for laparoscopic and robotic myomectomy procedures.
Results: The mean age, operation time, estimated blood loss, body mass index, largest fibroid diameter, length of hospital stay, and number of fibroids removed were comparable for both groups ( > .05). Symptom severity scores decreased significantly for both laparoscopic and robotic myomectomy patients at year after surgery ( < .05), and health-related quality of life scores increased significantly in both groups at 1 year after surgery ( < .05). Improvement in symptom severity and health quality was higher in the laparoscopy group; however, this was not statistically different from the robotic myomectomy group ( > .05).
Conclusion: Laparoscopic and robotic myomectomy provide significant reductions in fibroid-associated symptom severity and significant improvement in quality of life at 1 year after surgery. The rate of improvement was comparable for both procedures.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261743 | PMC |
| http://dx.doi.org/10.4293/JSLS.2018.00030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robot-Assisted Myomectomy versus Open Surgery : Cost-Effectiveness analysis: Cost-Effectiveness of Robotic Myomectomy.
J Gynecol Obstet Hum Reprod
December 2024
Assistance Publique-Hospitals of Paris, Department of Gynecological and Breast Surgery and Oncology, Pitié Salpêtrière Hospital, Paris, France; University Institute of Cancer (IUC), AP-HP, Sorbonne University, Paris, France; Saint-Antoine Research Center (CRSA), INSERM UMR_S_938, Biology and Therapeutics of Cancer, Sorbonne University, Paris, France. Electronic address:
Introduction: Fibroids are the most common benign uterine tumors. There are different possibilities for surgical approaches, and evaluating the cost of these operations is fundamental in modern surgery. The aim of our study is to evaluate the cost-effectiveness of robotic-assisted myomectomy (RAM) compared to open myomectomy (OM) in France.
View Article and Find Full Text PDFTransvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Benign Gynaecology: A Systematic Review of Adnexal, Myomectomy and Prolapse Procedures.
J Minim Invasive Gynecol
December 2024
University of Sydney, NSW, Australia; Sydney West Area Pelvic Surgical Unit (SWAPS), NSW, Australia; Department of Obstetrics and Gynaecology, Westmead Hospital, NSW, Australia.
Objective: Vaginal natural orifice transluminal endoscopic surgery (vNOTES) is utilised for gynaecological procedures globally, however evidence to support its application aside from hysterectomy is lacking. A systematic review to determine feasibility and safety profile of vNOTES for benign gynaecology was conducted.
Data Sources: A literature search of MEDLINE, EMBASE, CINAHL, SCOPUS and CENTRAL was conducted, including all types of studies reporting vNOTES for gynaecological indications.
The Impact of Minimally Invasive Gynecologic Surgery Subspecialty Training on Outcomes of Myomectomy: A Retrospective Cohort Study.
J Minim Invasive Gynecol
December 2024
Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center (Schneyer, Meyer, Barker, Hamilton, Siedhoff, Truong, and Wright), Los Angeles, California.
Article Synopsis
- The study aimed to compare the surgical outcomes of minimally invasive myomectomy (MIM) and abdominal myomectomy (AM) performed by fellowship-trained minimally invasive gynecologic surgery (MIGS) specialists versus general OB/GYNs.
- It was a retrospective cohort study involving 609 myomectomies conducted between 2015 and 2020 at a quaternary care institution, with a focus on the number of fibroids excised and complication rates.
- Results indicated that MIGS subspecialists had better surgical outcomes, including fewer perioperative complications and shorter surgery times for MIM, while no significant differences were found for AM between the two groups.
The Impact of Exclusively Virtual Preoperative Evaluation on Complications of Gynecologic Surgery.
J Minim Invasive Gynecol
November 2024
Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA.
Article Synopsis
- The study aimed to assess whether virtual preoperative evaluations have different effects on complication rates compared to in-person evaluations for minimally invasive gynecologic surgery.
- Conducted at a major academic hospital, the research analyzed data from nearly 3,000 patients who underwent procedures between 2016 and 2023, comparing outcomes between those who had virtual visits versus those who had in-person visits.
- Results showed no significant difference in overall complication rates (5.9% virtual vs. 6.3% in-person), indicating that virtual consultations are a viable alternative to in-person evaluations for this type of surgery.
Laparoscopic Robotic Assisted Surgery in Reproductive Medicine.
Arch Med Res
December 2024
Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, USA. Electronic address:
Article Synopsis
- Laparoscopic Robot-assisted surgery is a cutting-edge advancement in surgical technology, particularly benefiting reproductive medicine by enhancing fertility and providing innovative treatment options for gynecological conditions.
- Compared to traditional open surgery, it offers reduced post-surgical hospital stays and blood loss, with mixed results on operative times due to varying surgeon experience.
- Despite challenges like high costs and lack of tactile feedback, recent improvements—including the integration of Artificial Intelligence—are enhancing its applications for fertility preservation in female cancer survivors and other reproductive surgeries.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!